Bayesian Capital Management, LP Maravai Lifesciences Holdings, Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $379,034 - $649,773	74,175 New	74,175 $643,000
Q2 2022 Aug 15, 2022	SELL	$26.05 - $37.48 $407,552 - $586,374	-15,645 Reduced 47.92%	17,000 $483,000
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $670,204 - $1.12 Million	27,400 Added 522.4%	32,645 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $33,215 - $43,597	949 Added 22.09%	5,245 $220,000
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $158,092 - $260,423	4,296 New	4,296 $211,000

227

140M

237K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $650M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.